ArticleThe Journal of antimicrobial chemotherapy2021

In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19.

Carolina Q Sacramento et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.